Page last updated: 2024-10-29

iohexol and Myeloproliferative Disorders

iohexol has been researched along with Myeloproliferative Disorders in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stroszczynski, C1
Hosten, N1
Amthauer, H1
Ricke, J1
Ehrenstein, T1
Schedel, H1
Felix, R1
Fukuda, N1
Shinohara, K1
Shimohakamada, Y1

Other Studies

2 other studies available for iohexol and Myeloproliferative Disorders

ArticleYear
[Dynamic computerized tomography of the bone marrow of normal and pathologic vertebrae].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1997, Volume: 167, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Diseases; Bone Marrow Neopl

1997
Fatal cardiac arrest during infusion of nonionic contrast media in a patient with essential thrombocythemia.
    AJR. American journal of roentgenology, 2002, Volume: 178, Issue:3

    Topics: Contrast Media; Heart Arrest; Humans; Infusions, Intravenous; Iohexol; Male; Middle Aged; Myeloproli

2002